English | Español
Jamie Barrand | Feb 7, 2016

FDA to review Shire's second New Drug Application for dry eye therapy
Jamie Barrand | Feb 7, 2016

Mersana, Takeda partner on tumor therapy development
Jamie Barrand | Feb 5, 2016

Mind Your Risks campaign addresses link between high blood pressure, decreased brain function
Jamie Barrand | Feb 5, 2016

Spiriva Respimat approved in U.S. for asthma maintenance
Kasey Schefflin- Emrich | Feb 5, 2016

AbbVie's venetoclax cancer treatment receives FDA Breakthrough Therapy Designation
Jamie Barrand | Feb 5, 2016

CDC releases 2016 vaccination schedules for adults, children
Jamie Barrand | Feb 5, 2016

AHA study suggests increase in stroke risk for people over 60 with systolic blood pressure numbers above 140
Jamie Barrand | Feb 4, 2016

Collins, Klobuchar recommend increased funding for Alzheimer's research

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’